Company Overview
About Morphle Labs
Morphle Labs is a Bengaluru, India and Boston, Massachusetts-based robotic microscopy and digital pathology company — raising $5 million in Series A funding in November 2025 led by Inflexor Ventures — providing histopathology laboratories with AI-powered physical automation platforms that address the speed and throughput bottlenecks in cancer diagnostics workflows. With 80+ patents filed and products deployed in leading US and European laboratories, Morphle's 100-member team has developed two flagship platforms: RoboTome (a robotic microtome system that slices biopsy tissue blocks at 2x the speed of experienced histotechnologists) and MorphoLens (a high-throughput slide scanner that digitizes 100+ histology slides per hour for digital pathology review). Founded to "revolutionize cancer diagnostics with physical AI," Morphle expands manufacturing, regulatory clearances, and global presence with the Series A.
Business Model & Competitive Advantage
Morphle's digital pathology automation addresses the diagnostic throughput bottleneck that threatens cancer care capacity: pathology departments are facing a significant workforce shortage (the US has 20% fewer pathologists than needed, with demand growing as cancer incidence rises and diagnostic complexity increases) while the histopathology workflow — tissue processing, microtome sectioning, slide staining, mounting, and scanning — contains multiple manual steps that create throughput limitations and quality variability. RoboTome's robotic microtome (automating the delicate 4-micron tissue sectioning that requires trained histotechnologists to perform consistently under fatigue) addresses the tissue preparation bottleneck, while MorphoLens's 100+ slides/hour scanning rate (versus 15-20 slides/hour for standard laboratory scanners) digitizes the slide inventory that enables AI-assisted pathology review.
Competitive Landscape 2025–2026
In 2025, Morphle competes in the digital pathology, histopathology automation, and AI diagnostics market with Leica Biosystems (Danaher subsidiary, NASDAQ: DHR, histology automation), Hamamatsu (Japanese slide scanner manufacturer), and Paige AI (AI pathology, $70M raised) for pathology laboratory digital transformation and cancer diagnostics automation platform adoption. Inflexor Ventures' Series A leadership (Indian deep tech and healthcare VC) reflects conviction in Morphle's India-built hardware for global laboratory markets. The 80+ patent portfolio represents significant IP protection for the robotic microtome innovation. The 2025 strategy focuses on FDA 510(k) clearance for US laboratory deployment, growing European laboratory adoption through CE-marked scanner installation, and building the AI pathology analysis layer for automated slide reading alongside the physical automation platforms.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Morphle Labs is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Not So Random Others
AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Campfire
Campfire is a United States-based AI-native enterprise resource planning (ERP) company — backed by Y Combinator (S23) with $38.5 million raised including a $35 million Series A led by Accel in June 20
Oda Studio
Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal
Compare Morphle Labs with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Morphle Labs? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Morphle Labs Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Morphle Labs vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →